1.A phase II trial comparing pazopanib with doxorubicin as first-line treatment in elderly patients with metastatic or advanced soft tissue sarcoma (EPAZ): study protocol for a randomized controlled trial

作　　者：Annika Karch ;Armin Koch ;Viktor Grünwald

出　　处：Trials. 2016 ;17(1):1.doi:10.1186/s13063-016-1434-x

出版社：BioMed Central

文章 ID：181557982

文章详细全文下载
2.ACEMg-mediated hearing preservation in cochlear implant patients receiving different electrode lengths (PROHEARING): study protocol for a randomized controlled trial

作　　者：Verena Scheper ;Melanie Leifholz ;Heiko von der Leyen 等

出　　处：Trials. 2016 ;17(1):394.doi:10.1186/s13063-016-1526-7

出版社：BioMed Central

文章 ID：185389584

文章详细全文下载
3.Commentary: On the levels of patient selection in registry-based randomized controlled trials

作　　者：Florian Lasch ;Kristina Weber ;Armin Koch

出　　处：Trials. 2019 ;20(1):100-105.doi:10.1186/s13063-019-3214-x

出版社：BioMed Central

文章 ID：253248258

文章详细全文下载
4.Randomized placebo-controlled clinical trial investigating the effect of antioxidants and a vasodilator on overall safety and residual hearing preservation in cochlear implant patients

作　　者：Verena Scheper ;Melanie Schmidtheisler ;Florian Lasch 等

出　　处：Trials. 2020 ;21(1):1-14.doi:10.1186/s13063-020-04522-9

出版社：BioMed Central

文章 ID：251547634

文章详细全文下载
5.A multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)-specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograft recipients (IVIST01-trial): study protocol for a randomized controlled trial

作　　者：Thurid Ahlenstiel-Grunow ;Armin Koch ;Anika Großhennig 等

出　　处：Trials. 2014 ;15(1):324.doi:10.1186/1745-6215-15-324

出版社：BioMed Central

文章 ID：95192880

文章详细全文下载
6.Rationale and design of the RIACT–study: a multi-center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with B-cell infiltrates in renal Transplant patients: study protocol for a randomized controlled trial

作　　者：Lena Schiffer ;Mario Schiffer ;Saskia Merkel 等

出　　处：Trials. 2012 ;13(1):199.doi:10.1186/1745-6215-13-199

出版社：BioMed Central

文章 ID：95193666

文章详细全文下载
7.Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency

作　　者：Olivier Collignon ;Franz Koenig ;Armin Koch 等

出　　处：Trials. 2018 ;19(1):642.doi:10.1186/s13063-018-3012-x

出版社：BioMed Central

文章 ID：222403073

文章详细

	有本地全文	6篇
	有全文链接	1篇

	Thomas Lenarz	2篇
	Verena Scheper	2篇
	Agnès Saint-Raymond	1篇
	Alexander A Zoerner	1篇
	Andreas Büchner	1篇
	Anke Lesinski-Schiedat	1篇
	Anke Schwarz	1篇
	Christoph Schroeder	1篇
	Christoph Schröder	1篇
	Christopher Jürgens	1篇
	Cornelia Frömke	1篇
	Frank Biertz	1篇
	Frank Pétavy	1篇
	Franz Koenig	1篇
	Hermann Haller	1篇
	Jan U Becker	1篇
	Jana Schwieger	1篇
	Jana Träder	1篇
	Josef Miller	1篇
	Kerstin Püllmann	1篇
	Kristina Weber	1篇
	Lars Pape	1篇
	Lena Schiffer	1篇
	Mario Schiffer	1篇
	Marisa Papaluca-Amati	1篇
	Martin Posch	1篇
	Martina Sester	1篇
	Maximilian E Dämmrich	1篇
	Melanie Leifholz	1篇
	Melanie Schmidtheisler	1篇
	Michael Mengel	1篇
	Miriam Keller	1篇
	Olivier Collignon	1篇
	Robert James Hemmings	1篇
	Saskia Merkel	1篇

全文

出版年度

作者

文章类型

来源期刊

学科主题

语种

国别/地区

检索条件:"( ( 高级检索(( ((AU:(("Armin Koch")))) )) ) )"

	Armin Koch	7篇
	Anika Großhennig	2篇
	Annika Karch	2篇
	Florian Lasch	2篇
	Heiko von der Leyen	2篇

	2020	1篇
	2019	1篇
	2018	1篇
	2016	2篇
	2014	1篇